Shaunna Herrman
Physician Assistant · Wade, NCNPI 1023053006
Payments from drug & device makers
Across 114 payments — averaging $17.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$363
- Boehringer Ingelheim$358
- GSK$159
- Johnson & Johnson$149
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$144
- Lilly USA, LLC$127
- plus $655 from 19 others
What the payments were for
- Food & beverage$1,954100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 21 | $363 |
| Boehringer Ingelheim | 18 | $358 |
| GSK | 10 | $159 |
| Johnson & Johnson(2 entities) | 10 | $149 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $144 |
| Lilly USA, LLC | 9 | $127 |
| AstraZeneca | 7 | $121 |
| Sanofi-aventis U.S. LLC | 7 | $116 |
| AbbVie | 5 | $101 |
| Pfizer | 2 | $41 |
| Bayer | 2 | $31 |
| Biohaven Pharmaceuticals, Inc. | 2 | $30 |
| Mylan Specialty L.p. | 1 | $26 |
| Dexcom, Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Merck | 1 | $17 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Scpharmaceuticals Inc. | 1 | $16 |
| Amgen | 1 | $16 |
| Shield Therapeutics Inc | 1 | $16 |
| Novartis | 1 | $15 |
| Exact Sciences | 1 | $15 |
| Alkermes, Inc. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
How this compares
$1,954 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ShingrixVaricella-Zoster Ge/As01b/Pf | 81 | $18,063 |
| FarxigaDapagliflozin Propanediol | 11 | $15,902 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 49 | $15,393 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 18 | $10,387 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $6,421 |
| Adacel TdapDiph,pertuss(Acell),tet Vac/Pf | 36 | $2,539 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 13 | $814 |
| Gabapentin | 31 | $558 |
| Metoprolol Succinate | 26 | $525 |
| Fluticasone Propionate | 21 | $476 |
| Omeprazole | 42 | $464 |
| Atorvastatin Calcium | 56 | $404 |
| Valsartan | 14 | $323 |
| Amlodipine Besylate | 59 | $308 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $260 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKShingrix, Arexvy, Breo Ellipta | $159 | $39,876142 claims |
| AstraZenecaFarxiga | $121 | $15,90211 claims |
| MerckJanumet Xr | $17 | $10,38718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Wade
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
- Kristin CabedaCharlotte$135K
- Jay ClarkeArden$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.